Showing results (41-50 of 131) with videos related to
Sort By:
Pageof 14
AIDS Research and Therapy|February 15, 2011
Control of viral replication after cessation of HAARTEllen Van Gulck, Leo Heyndrickx, Lotte Bracke, et al.The Journal of Antimicrobial Chemotherapy|February 14, 2008
CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicidesYven Van Herrewege, Laurence Morellato, Anne Descours, et al.AIDS Research and Human Retroviruses|November 6, 2009
HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodiesTessa Dieltjens, Nathalie Loots, Katleen Vereecken, et al.Current HIV Research|January 24, 2012
Reverse transcriptase inhibitors as microbicidesPaul Lewi, Jan Heeres, Kevin Ariën, et al.AIDS Research and Human Retroviruses|October 25, 2002
Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmissionYven Van Herrewege, Lieve Penne, Chris Vereecken, et al.Antimicrobial Agents and Chemotherapy|May 14, 2008
Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infectionKatty Terrazas-Aranda, Yven Van Herrewege, Daria Hazuda, et al.Journal of Immunological Methods|January 30, 2007
The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infectionSophia Steyaert, Lieven Verhoye, Els Beirnaert, et al.Retrovirology|May 4, 2012
MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiencyKatrijn Grupping, Philippe Selhorst, Johan Michiels, et al.Current HIV Research|May 14, 2008
CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptorKurt Vermeire, Joachim Brouwers, Yven Van Herrewege, et al.Journal of Virological Methods|July 20, 2010
Unravelling the antigenic landscape of the HIV-1 subtype A envelope of an individual with broad cross-neutralizing antibodies using phage display peptide librariesTessa Dieltjens, Betty Willems, Sandra Coppens, et al.Pageof 14